Pot producers look past retail, focus on medical, IP for long-term revenues
TORONTO — Canadians are counting down to the legalization of recreational marijuana this summer, but industry players are already racing to get ahead in a potentially more lucrative market segment for the plant in the years to come: cannabis-based pharmaceuticals.
No Comments